Ensysce Biosciences Stock (NASDAQ: ENSC) stock price, news, charts, stock research, profile.
Open | $0.33 |
Close | $0.32 |
Volume / Avg. | 191.51K / 1.77M |
Day Range | $0.32 - $0.34 |
52 Wk Range | 0.31 - 2.06 |
Market Cap | $2.73M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 8.31% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ensysce Biosciences (NASDAQ:ENSC) through any online brokerage.
Other companies in Ensysce Biosciences’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Tonix Pharmaceuticals (NASDAQ:TNXP).
Ensysce Biosciences has a consensus price target of $7.50.
The stock price for Ensysce Biosciences (NASDAQ: ENSC) is $0.322 last updated September 20, 2024 at 5:11 PM EDT.
There are no upcoming dividends for Ensysce Biosciences.
Ensysce Biosciences’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Ensysce Biosciences.
Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.